Thank you, Sally, and good morning, good afternoon, good evening to all of our shareholders, and welcome to all to ResMed's second quarter fiscal year 2026 earnings call. For this March and the June ...
Landmark rule change follows years of public debate—and highlights the real-world impact of attorney Nelson A. Locke’s ...
In this week’s edition of The Prototype, we look at how a new discovery could lead to unsinkable ships, the billions invested ...
New white-label platform analyzes 100% of customer conversations and delivers tasks, alerts, coaching, and executive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results